Literature DB >> 25919492

Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis.

J Santos-Juanes1, I Fernández-Vega2, N Fuentes1, C Galache3, P Coto-Segura4, B Vivanco1, A Astudillo1, P Martínez-Camblor5,6.   

Abstract

Several observational studies have assessed the correlation between Merkel cell carcinoma and Merkel cell polyomavirus with variable results. The objective of this systematic review was to determine whether there is a correlation between Merkel cell carcinoma and Merkel cell polyomavirus. Studies assessing the relationship between Merkel cell carcinoma and Merkel cell polyomavirus from January 2008 to August 2014 were pooled from Medline, Embase, PubMed, Cochrane Database of Systemic Reviews and Google Scholar. From each study we collected the first author's last name, publication year, country of origin, type of study design, characteristics of participants, possible variables incorporated into the multivariable analyses and the risk ratio (RR) for Merkel cell carcinoma associated with Merkel cell polyomavirus combined with the corresponding 95% confidence interval (CI). Methodological assessment of the study was evaluated using the Newcastle-Ottawa scale. Crude RR was calculated from the data provided in each article. Meta-analyses for the global RR and for the proportion of positives in both case and control samples were performed. In addition, in order to explore the sources of heterogeneity among the studies, meta-regression and sensitivity analyses are also provided. A total of 22 studies were identified for the analysis. The pooled RR from random-effects analysis was determined to be 6.32 (95% CI, 4.02-9.93). Global proportions of positive samples were 0.79 (95% CI, 0.72-0.84) and 0.12 (95% CI, 0.08-0.19) in the case and control groups, respectively. The findings support the association between Merkel cell carcinoma and Merkel cell polyomavirus. However, a non-negligible percentage of positive results have been identified in controls. Some caution must be taken in the interpretation of these results because heterogeneity between studies was found.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2015        PMID: 25919492     DOI: 10.1111/bjd.13870

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  18 in total

1.  The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment.

Authors:  Andreas Stang; Jürgen C Becker; Paul Nghiem; Jacques Ferlay
Journal:  Eur J Cancer       Date:  2018-03-20       Impact factor: 9.162

2.  Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

Authors:  Howard L Kaufman; Jeffery Russell; Omid Hamid; Shailender Bhatia; Patrick Terheyden; Sandra P D'Angelo; Kent C Shih; Céleste Lebbé; Gerald P Linette; Michele Milella; Isaac Brownell; Karl D Lewis; Jochen H Lorch; Kevin Chin; Lisa Mahnke; Anja von Heydebreck; Jean-Marie Cuillerot; Paul Nghiem
Journal:  Lancet Oncol       Date:  2016-09-01       Impact factor: 41.316

3.  The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.

Authors:  Todd C Knepper; Meagan Montesion; Jeffery S Russell; Ethan S Sokol; Garrett M Frampton; Vincent A Miller; Lee A Albacker; Howard L McLeod; Zeynep Eroglu; Nikhil I Khushalani; Vernon K Sondak; Jane L Messina; Michael J Schell; James A DeCaprio; Kenneth Y Tsai; Andrew S Brohl
Journal:  Clin Cancer Res       Date:  2019-08-09       Impact factor: 12.531

4.  Tropomyosin Receptor Kinase A Expression on Merkel Cell Carcinoma Cells.

Authors:  Ulrike Wehkamp; Sophie Stern; Sandra Krüger; Axel Hauschild; Christoph Röcken; Friederike Egberts
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

5.  Metastatic Merkel-cell carcinoma: the dawn of a new era.

Authors:  Timothy O'Brien; Derek G Power
Journal:  BMJ Case Rep       Date:  2018-07-11

6.  Co-expression of NGF and PD-L1 on tumor-associated immune cells in the microenvironment of Merkel cell carcinoma.

Authors:  Ulrike Wehkamp; Sophie Stern; Sandra Krüger; Michael Weichenthal; Axel Hauschild; Christoph Röcken; Friederike Egberts
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-09       Impact factor: 4.553

7.  Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Rachel Blitzblau; Glen M Bowen; Carlo M Contreras; Gregory A Daniels; Roy Decker; Jeffrey M Farma; Kris Fisher; Brian Gastman; Karthik Ghosh; Roy C Grekin; Kenneth Grossman; Alan L Ho; Karl D Lewis; Manisha Loss; Daniel D Lydiatt; Jane Messina; Kishwer S Nehal; Paul Nghiem; Igor Puzanov; Chrysalyne D Schmults; Ashok R Shaha; Valencia Thomas; Yaohui G Xu; John A Zic; Karin G Hoffmann; Anita M Engh
Journal:  J Natl Compr Canc Netw       Date:  2018-06       Impact factor: 12.693

Review 8.  Human Polyomaviruses: The Battle of Large and Small Tumor Antigens.

Authors:  Camila Freze Baez; Rafael Brandão Varella; Sonia Villani; Serena Delbue
Journal:  Virology (Auckl)       Date:  2017-12-05

9.  An elderly man with a solitary liver lesion.

Authors:  Lisa Barton; Lichao Zhao; Jessica N Doty; Thomas Stasko; Rachel Conrad
Journal:  Cytojournal       Date:  2017-05-26       Impact factor: 2.091

Review 10.  Interesting case of an abdominal wall Merkel cell carcinoma highlighting the importance of developing an Australian clinical practice guideline.

Authors:  Anthony-Joe Nassour; Darius Ashrafi; Kevin Lah; Suntharalingham Sivananthan
Journal:  BMJ Case Rep       Date:  2020-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.